Detection of prostate and colon cancer

JAMA

Volumn 280, Issue 2, 1998, Pages 117-118

  Stern, Scott ^a   Altkorn, Diane ^a   Levinson, Wendy ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; BARIUM ENEMA; CANCER RISK; CANCER SCREENING; COLON CANCER; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEMORRHOID; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECTOSCOPY; RECTUM POLYP; REVIEW;

EID: 0032496892     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.2.117     Document Type: Review

References (16)

1. von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer. 1997;80:1805-1807.
2. Report of the US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing Inc; 1996. Available at: http://158.72.20.10/pubs /guidecps. Accessed June 5, 1998.
3. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.
4. Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley A. Early detection of prostate cancer, II: estimating the risks, benefits, and costs. Ann Intern Med. 1997;126:468-479.
5. Ventura SJ, Peters KD, Martin JA, Maurer JD. Births and deaths: United States, 1996. Mon Vital Stat Rep. 1997;46(1[suppl 2]).
6. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. JAMA. 1997;277:1452-1455.
7. Smart CR. The results of prostate carcinoma screening in the US as reflected in the Surveillance, Epidemiology, and End Results Program. Cancer. 1997;80:1835-1844.
8. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 1995; 273:289-294.
9. Brawley OW. Prostate carcinoma incidence and patient mortality. Cancer. 1997;80:1857-1863.
10. Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO. Fifteen-year survival in prostate cancer: a prospective population-based study in Sweden. JAMA. 1997;277:467-471.
11. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer, I: prior probability and effectiveness of tests. Ann Intern Med. 1997; 126:394-406.
12. Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 1993;42:365-374.
13. American College of Physicians. Screening for prostate cancer. Ann Intern Med. 1997;126:480-484.
14. Read TE, Read JD, Butterly LF. Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med. 1997;336:8-12.
15. Helfand M, Marton KI, Zimmer-Gembeck MJ, Sox HC Jr. History of visible rectal bleeding in a primary care population: initial assessment and 10-year follow-up. JAMA. 1997;277:44-48.
16. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.